Evaluating the efficacy of Antiseptic neem liquid & Antiseptic neem gel in subjects with various skin conditions.
- Conditions
- Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
- Registration Number
- CTRI/2023/10/058801
- Lead Sponsor
- Saumitra Pal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
1.Healthy males & female subjects in the age group of 13-45 years (both age inclusive).
2.Subject is having valid proof of identity and age.
3.Males & females having prickly heat/ mosquito bite/ irritation due to summer or monsoon due to heat and sweat/ recent cut/ recent minor burn.
4.Subjects representing normal, oily, dry and combination skin.
5.Subjects willing to give voluntary written informed consent.
6.Subjects willing to come for regular follow-up visits.
7.Subjects ready to follow instructions during the study period.
8.Subject willing to perform UPT (for females only).
1.Subjects with Known hypersensitivity to any of the study products or constituents.
2.Subjects having topical or systemic treatment in the last month prior to participation in the study and during the study that could interfere with the study treatments/ assessments.
3.Subject is Pregnant or Lactating.
4.Subject with any significant medical condition that would interfere with the participation in the trial.
5.Subjects participated in any other cosmetic or therapeutic trial or in a similar investigation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 Reduction in Miliaria symptoms like reduction in eruption size number area covered pruritus erythema edema and excoriation <br/ ><br>2 Reduction in discomfort like burning itching tingling and stingingTimepoint: Day 0 Screening and Baseline Day 3 Day 7 and Day 14.
- Secondary Outcome Measures
Name Time Method Reduction in discomfort like burning itching tingling and stingingTimepoint: Day 0 Screening and Baseline Day 3 Day 7 and Day 14.